Results 111 to 120 of about 141,545 (201)

Prostaglandin E2 Reverses the Effects of DNA Methyltransferase Inhibitor and TGFB1 on the Conversion of Naive T Cells to iTregs. [PDF]

Transfus Med Hemother, 2020
Sahin M, Sahin E.
europepmc   +1 more source

Triplet Therapy with PD-1 Blockade, Histone Deacetylase Inhibitor, and DNA Methyltransferase Inhibitor Achieves Radiological Response in Refractory Double-Expressor Diffuse Large B-cell Lymphoma with 17p Deletion. [PDF]

Case Rep Hematol, 2020
Zheng R, Chen X, Wang C, Qin P, Tan H, Luo X.   +5 more
europepmc   +1 more source

The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer. [PDF]

BMC Immunol, 2020
Luker AJ, Graham LJ, Smith TM, Camarena C, Zellner MP, Gilmer JS, Damle SR, Conrad DH, Bear HD, Martin RK.   +9 more
europepmc   +1 more source

Effects of Treatment with a DNA Methyltransferase Inhibitor 5-aza-dC on Sex Differentiation in Medaka (<i>Oryzias latipes</i>). [PDF]

Int J Mol Sci
Cui X, Xu L, Tian N, Peng J.
europepmc   +1 more source

Regulation of major histocompatibility complex class-I (MHC-I) gene methylation using DNA methyltransferase inhibitor and PD-L1 inhibitor in triple negative breast cancer. [PDF]

Discov Oncol
Jeong YJ, Lee NR, Oh HK.
europepmc   +1 more source

Structure, function and regulation of mammalian DNA methyltransferase [PDF]

, 1993
A Bolden, A Czank, A Lahm, AD Riggs, C. Lange, D Jahner, D Simon, D. Ingrosso, DV Santi, E Flatau, E Li, F Antequera, F Antequera, GP Pfeifer, GP Pfeifer, GP Pfeifer, J Posfai, J-P Jost, JC Wu, JR Chaillet, K. K. Hubrich, KE Zucker, KR Fox, L Chen, LA Sznyter, M Monk, M Monk, MN Schwartz, P Engler, P Renbaum, R Holliday, R. Lauster, RL Adams, RLP Adams, RR Meehan, S Klimasauskas, SK Howlett, SL Mansour, T Bestor, T Bestor, T Bestor, T Bestor, TH Bestor, TH Bestor, Y Gruenbaum, Y Gruenbaum, Y Uehara   +46 more
core   +1 more source

The DNA methyltransferase inhibitor decitabine blunts the response to a high-animal fat and protein diet in mice. [PDF]

J Lipid Res
Flores-Sierra JJ, Muciño-Arellano MDR, Romo-Morales GDC, Sánchez-Palafox JE, Correa-Navarro VA, Colín-Castelán D, Pérez-Vázquez V, Rangel-Salazar R, Rivera-Bustamante R, de la Rocha C, Rodríguez-Ríos D, Trejo-Saavedra DL, Molina-Torres J, Ramírez-Chávez E, García-Rojas NS, Winkler R, Lund G, Zaina S.   +17 more
europepmc   +1 more source

The DNA Methyltransferase Inhibitor 5-Aza-4'-thio-2'-Deoxycytidine Induces C>G Transversions and Acute Lymphoid Leukemia Development. [PDF]

Cancer Res
Bertoli RM, Chung YJ, Difilippantonio MJ, Wokasch A, Marasco MRB, Klimaszewski H, Gammell S, Zhu YJ, Walker RL, Cao D, Khanna A, Walter MJ, Doroshow JH, Meltzer PS, Aplan PD.   +14 more
europepmc   +1 more source

Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI-110) in Hepatocellular Carcinoma. [PDF]

Hepatology, 2018
Liu M, Zhang L, Li H, Hinoue T, Zhou W, Ohtani H, El-Khoueiry A, Daniels J, O'Connell C, Dorff TB, Lu Q, Weisenberger DJ, Liang G.   +12 more
europepmc   +1 more source

A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors. [PDF]

Cancer, 2019
Gaillard SL, Zahurak M, Sharma A, Durham JN, Reiss KA, Sartorius-Mergenthaler S, Downs M, Anders NM, Ahuja N, Rudek MA, Azad N.   +10 more
europepmc   +1 more source